FDA approves 1st self-administered flu vaccine
FDA approves first flu vaccine that can be self-administered at home
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered flu vaccine option.
FDA approves FluMist for self-administration
The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
At-home nasal spray flu vaccine coming next year
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and Drug Administration expanded its approval of AstraZeneca's FluMist. Why it matters: It will be the first flu vaccine that doesn't need to be administered by a health provider and will be sold direct to consumers for home use via an online pharmacy.
At-home flu vaccine authorized by FDA
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be prescribed before purchase.
EBGLYSS for eczema: What to know about the newly FDA-approved drug from Eli Lilly
The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...
JD Supra2h
New FDA clinical trials guidances promote efficient drug development, innovative designs, diversity
The U.S. Food and Drug Administration (FDA) issued this week three guidance documents related to clinical trials: a draft ...
Medscape2h
FDA Approves Bimekizumab for Three Rheumatologic Conditions
The US Food and Drug Administration has approved bimekizumab -bkzx (Bimzelx; UCB) for adult patients with active psoriatic ...
FiercePharma7h
UCB rapidly bolsters blockbuster potential for Bimzelx with 3 new FDA approvals
Less than a year after snagging its first FDA approval in psoriasis, UCB’s blockbuster hopeful Bimzelx has picked up three ...
ConsumerAffairs3h
FDA finds that some 'dairy-free' chocolates aren’t
When is “dairy-free” actually dairy-free? If you’re one of the nearly 30 million American adults who have some degree of ...
medtechdive3h
FDA posts draft guidance on biocompatibility testing of devices
To promote consistency and reliability in analytical chemistry studies for premarket submissions, the FDA shared recommended approaches for device biocompatibility analysis.
Sierra Sun Times5h
FDA on Braces and Aligners - Braces Have Changed, From Metal to Tooth-Colored to Clear
A: Braces move teeth by applying pressure and usually consist of small metal, ceramic, or plastic brackets cemented to your ...
dvm3603h
FDA announces Smiths Medical ventilator recall
The FDA's Center for Veterinary Medicine (CVM) announced Smiths Medical’s recall of the PneuPAC paraPAC Plus P300 and ...
Convenience Store News2h
FDA Seeks Civil Money Penalties Against 11 Retailers Selling Unauthorized E-Cigarettes
The Food and Drug Administration is seeking civil money penalties (CMP) against two brick-and-mortar retailers and nine ...